Dr. Douglas Faller

Imunon, Inc. (IMNN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Imunon, Inc. publishes a filing, an earnings call transcript or a press release.

Get IMNN alerts

About Dr. Douglas Faller

Dr. Douglas Faller has spoken on 1 earnings call across 1 company, most recently for Imunon, Inc. on March 31, 2026. Imunon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Imunon, Inc. includes Corinne Le Goff (CEO and Board Member), Michael Tardugno (CEO and Chairman), Stacy Lindborg (CEO and Board Member) and 7 others.

Dr. Douglas Faller on recent calls

“The enthusiasm within the gynecologic community that we saw at our R&D day in November and throughout 2025 has only grown.”

Other, Imunon, Inc. Q4 FY2025 Earnings Call · March 31, 2026

Affiliation history

Imunon, Inc. (IMNN)
SEC 8-K

Current
2025-02-18–present

Company network

IMNN

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-03-31

View calls and events

Leadership on record at Imunon, Inc.

Corinne Le Goff CEO, Board Member
Michael Tardugno CEO, Chairman
Stacy Lindborg CEO, Board Member
Stacy R. Lindborg CEO, Board Member
Stacy R. Lindborg, Ph.D. CEO
Michael H. Tardugno Chairman
David Gaiero CFO
Josh Blacher CFO
Kimberly Graper CFO
Susan Eylward General Counsel

Recent activity

Earnings call Imunon, Inc. Q4 FY2025 Earnings Call Imunon, Inc. (IMNN)
2026-03-31